KIDS
OrthoPediatrics Corp.
KIDS lost money over the past year, so it has no meaningful PE right now. Analysts expect losses to shrink.
KIDS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Under pressure | |
| Stable | |
| Unavailable |
KIDS's revenue is currently healthy, and its cash flow is stable, but its profitability is under pressure. There isn't enough data to rate its balance sheet.
KIDS PE Valuation
KIDS has no meaningful PE right now: it lost money over the past year.
KIDS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Growth | |
| Strongly improving | |
| Limited | |
| High |
Analysts expect KIDS's losses to shrink, with revenue growing.
KIDS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$1.43 | +$0.53 |
| Q2 2026 | -$1.68 | +$0.12 |
| Q1 2026 | -$1.68 | +$0.08 |
| Q4 2025 | -$1.69 | -$0.05 |
| Q3 2025 | -$1.96 | -$0.73 |
| Q2 2025 | -$1.80 | -$0.71 |
| Q1 2025 | -$1.76 | -$0.80 |
| Q4 2024 | -$1.64 | -$0.72 |
KIDS is still losing money, but less than at its worst: $1.43 per share over the past year, against $2.05 at its worst in early 2021.
KIDS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $72.7M | +19% |
| Q2 2026 | $70.5M | +15% |
| Q1 2026 | $59.4M | +13% |
| Q4 2025 | $61.6M | +17% |
| Q3 2025 | $61.3M | +12% |
| Q2 2025 | $61.1M | +16% |
| Q1 2025 | $52.4M | +17% |
| Q4 2024 | $52.7M | +40% |
KIDS's revenue has grown year over year for 23 quarters in a row: $73M last quarter, up 19% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -5.8% | +9.6 points |
| Q2 2026 | -5.8% | +12 points |
| Q1 2026 | -14% | +6.9 points |
| Q4 2025 | -13% | +13 points |
| Q3 2025 | -15% | -5.2 points |
| Q2 2025 | -17% | -6.7 points |
| Q1 2025 | -21% | +0.8 points |
| Q4 2024 | -27% | -5.3 points |
KIDS's operating margin was −5.8% last quarter, up 9.6 points from the same quarter a year ago, near the top of its range since 2019.
KIDS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $1.6M | +$5M |
| Q2 2026 | -$3.1M | +$10.8M |
| Q1 2026 | -$5M | +$3.3M |
| Q4 2025 | $9.7M | +$13.5M |
| Q3 2025 | -$3.4M | +$8.2M |
| Q2 2025 | -$13.9M | -$1.1M |
| Q1 2025 | -$8.4M | +$4.8M |
| Q4 2024 | -$3.7M | +$7.7M |
KIDS's free cash flow has turned positive after six years mostly in the red: $3M over the past year.
KIDS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.4% | +105K shares |
| 1 year | +2.5% | +588K shares |
| 3 years | +6.1% | +1.4M shares |
| 5 years | +25% | +4.9M shares |
| Available history | +65% | +9.5M shares |
KIDS has 24M diluted shares, up 2.5% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2021 | — |
| Q1 2020 | $187,000 |
KIDS Net Leverage
KIDS's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
KIDS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 78.2 | Overbought |
| Stochastic | 84.8 | Overbought |
KIDS's weekly RSI is 78 (overbought) and its Stochastic is 85 (overbought).
KIDS PE vs Healthcare Sector
| Metric | KIDS | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
KIDS has no meaningful PE right now: it lost money over the past year.
KIDS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $26.0 | 25% above |
| 20 week MA | $23.5 | 39% above |
| 50 week MA | $19.9 | 64% above |
| 100 week MA | $20.6 | 58% above |
| 200 week MA | $27.3 | 19% above |
KIDS has climbed back above all five of its weekly moving averages, and it's now 19% above its 200-week average.
KIDS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $46.5 | $46.3 | -0.4% |
| 2021 | $46.3 | $60.8 | +31% |
| 2022 | $60.8 | $38.0 | -37% |
| 2023 | $38.0 | $32.5 | -14% |
| 2024 | $32.5 | $22.9 | -30% |
| 2025 | $22.9 | $17.3 | -24% |
| 2026 YTD | $17.3 | $32.6 | +88% |
KIDS has finished four years in a row lower, and it's up 88% so far in 2026.